IL6 and Myocardial fibrosis: QSYQ down-regulated the TNF-α-NF-κB and IL-6-STAT3 signaling pathways that QSYQ inhibited type I and type II collagen synthesis, thereby improving myocardial remodeling and inhibiting myocardial fibrosis (270).